Partial and full agonists of A1 adenosine receptors

Details for Australian Patent Application No. 2003223237 (hide)

International Classifications

Event Publications

7 August 2003 Complete Application Filed

Priority application(s): 60/357,961 19.02.02 US

9 October 2003 Application Open to Public Inspection

Published as AU-B-2003223237

21 August 2008 Application Accepted

Published as AU-B-2003223237

11 December 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 17 Sep 2008. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Mebourne VIC 3000

26 March 2009 Standard Patent Sealed

15 October 2009 Amendment Made

The nature of the amendment is: Amend the patentee name from CV Therapeutics, Inc. to Gilead Palo Alto, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.